These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29096557)

  • 1. NOD2 and bacterial recognition as therapeutic targets for Crohn's disease.
    de Bruyn M; Vermeire S
    Expert Opin Ther Targets; 2017 Dec; 21(12):1123-1139. PubMed ID: 29096557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of NOD2 Variants on Fecal Microbiota in Crohn's Disease and Controls Without Gastrointestinal Disease.
    Kennedy NA; Lamb CA; Berry SH; Walker AW; Mansfield J; Parkes M; Simpkins R; Tremelling M; Nutland S; ; Parkhill J; Probert C; Hold GL; Lees CW
    Inflamm Bowel Dis; 2018 Feb; 24(3):583-592. PubMed ID: 29462388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crohn's disease: a role of gut microbiota and Nod2 gene polymorphisms in disease pathogenesis.
    Hrnčířová L; Krejsek J; Šplíchal I; Hrnčíř T
    Acta Medica (Hradec Kralove); 2014; 57(3):89-96. PubMed ID: 25649363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NOD2 p.Leu1007fsX1008 mutation (rs2066847) is a stronger predictor of the clinical course of Crohn's disease than the FOXO3A intron variant rs12212067.
    Schnitzler F; Friedrich M; Wolf C; Angelberger M; Diegelmann J; Olszak T; Beigel F; Tillack C; Stallhofer J; Göke B; Glas J; Lohse P; Brand S
    PLoS One; 2014; 9(11):e108503. PubMed ID: 25365249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
    Strober W; Asano N; Fuss I; Kitani A; Watanabe T
    Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn's disease subjects.
    Turpin W; Bedrani L; Espin-Garcia O; Xu W; Silverberg MS; Smith MI; Garay JAR; Lee SH; Guttman DS; Griffiths A; Moayyedi P; Panaccione R; Huynh H; Steinhart HA; Aumais G; Dieleman LA; Turner D; ; Paterson AD; Croitoru K
    BMC Med Genet; 2020 Oct; 21(1):204. PubMed ID: 33059653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immune defence: NOD2 and autophagy in the pathogenesis of Crohn's disease.
    Hruz P; Eckmann L
    Swiss Med Wkly; 2010; 140():w13135. PubMed ID: 21213148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of NOD2 on the microbiota in Crohn's disease.
    Lauro ML; Burch JM; Grimes CL
    Curr Opin Biotechnol; 2016 Aug; 40():97-102. PubMed ID: 27035071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOD2/CARD15 mutations in Polish and Bosnian populations with and without Crohn's disease: prevalence and genotype-phenotype analysis.
    Salkic NN; Adler G; Zawada I; Alibegovic E; Karakiewicz B; Kozlowska-Wiechowska A; Wasilewicz M; Sulzyc-Bielicka V; Bielicki D
    Bosn J Basic Med Sci; 2015 May; 15(2):67-72. PubMed ID: 26042516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease.
    Schwerd T; Pandey S; Yang HT; Bagola K; Jameson E; Jung J; Lachmann RH; Shah N; Patel SY; Booth C; Runz H; Düker G; Bettels R; Rohrbach M; Kugathasan S; Chapel H; Keshav S; Elkadri A; Platt N; Muise AM; Koletzko S; Xavier RJ; Marquardt T; Powrie F; Wraith JE; Gyrd-Hansen M; Platt FM; Uhlig HH
    Gut; 2017 Jun; 66(6):1060-1073. PubMed ID: 26953272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [NOD2 gene mutation in Moroccan patients with Crohn's disease: prevalence, genotypic study and correlation of NOD2 gene mutation with the phenotype of Crohn's disease].
    Tamzaourte M; Errabih I; Krami H; Maha F; Maria L; Benzzoubeir N; Ouazzani L; Sefiani A; Ouazzani H
    Pan Afr Med J; 2017; 27():116. PubMed ID: 28819537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complex interplay of NOD-like receptors and the autophagy machinery in the pathophysiology of Crohn disease.
    Billmann-Born S; Lipinski S; Böck J; Till A; Rosenstiel P; Schreiber S
    Eur J Cell Biol; 2011; 90(6-7):593-602. PubMed ID: 21146253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy and inflammatory bowel disease: Association between variants of the autophagy-related IRGM gene and susceptibility to Crohn's disease.
    Rufini S; Ciccacci C; Di Fusco D; Ruffa A; Pallone F; Novelli G; Biancone L; Borgiani P
    Dig Liver Dis; 2015 Sep; 47(9):744-50. PubMed ID: 26066377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysbiotic gut microbiome: A key element of Crohn's disease.
    Øyri SF; Műzes G; Sipos F
    Comp Immunol Microbiol Infect Dis; 2015 Dec; 43():36-49. PubMed ID: 26616659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crohn's disease: NOD2, autophagy and ER stress converge.
    Fritz T; Niederreiter L; Adolph T; Blumberg RS; Kaser A
    Gut; 2011 Nov; 60(11):1580-8. PubMed ID: 21252204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project.
    Cleynen I; González JR; Figueroa C; Franke A; McGovern D; Bortlík M; Crusius BJ; Vecchi M; Artieda M; Szczypiorska M; Bethge J; Arteta D; Ayala E; Danese S; van Hogezand RA; Panés J; Peña SA; Lukas M; Jewell DP; Schreiber S; Vermeire S; Sans M
    Gut; 2013 Nov; 62(11):1556-65. PubMed ID: 23263249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Association Analysis Reveals Differences in the Contribution of NOD2 Variants to the Clinical Phenotypes of Orofacial Granulomatosis.
    Mentzer A; Nayee S; Omar Y; Hullah E; Taylor K; Goel R; Bye H; Shembesh T; Elliott TR; Campbell H; Patel P; Nolan A; Mansfield J; Challacombe S; Escudier M; Mathew CG; Sanderson JD; Prescott NJ
    Inflamm Bowel Dis; 2016 Jul; 22(7):1552-8. PubMed ID: 27306066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation.
    Cooney R; Baker J; Brain O; Danis B; Pichulik T; Allan P; Ferguson DJ; Campbell BJ; Jewell D; Simmons A
    Nat Med; 2010 Jan; 16(1):90-7. PubMed ID: 19966812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Toll-like receptor 10 and susceptibility to Crohn's disease independent of NOD2.
    Abad C; González-Escribano MF; Diaz-Gallo LM; Lucena-Soto JM; Márquez JL; Leo E; Crivell C; Gómez-García M; Martín J; Núñez-Roldán A; García-Lozano JR
    Genes Immun; 2011 Dec; 12(8):635-42. PubMed ID: 21716313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.